Yes indeed felt nice this morning to wake up with some eyebrows hehe..thanks all of you lovely ladies for your imput,
and thanks for agreeing Steph I 'll send you a pic direct!
Other yes latisse.. as I said in other post I am in two minds about this. Allergan are also the maker of Botox also FDA approved, so is trans fat: FDA approved.. not a label of safety by no means..
Sorry I know that the benefit is for many outweighting the risk and as individual everyone should make their choice and I would support anyone using it! (I WANT TO MAKE THAT CLEAR)
However I have noticed that the active ingredient in latisse is prostagladin, a growth factor that has been linked to acceleration of most cancers tumours including breast
for example :
http://www.ncbi.nlm.nih.gov/pubmed/16118353
Now it is likely that it is not important enough a dosage to activate receptors in breast and other areas of body and as yet no one had tumours in eyelid I would agree. But it is now known that botox for example travel to other sites than the face so for my part (at the moment at least) I will look for alternative. I suppose if I had been using it and only required to put it on once a week now then I would continue, but not sure I want to start putting it on everyday..
That's my 2 cents on it, now everyone make their own choices..
__________________
35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies
Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009:
to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..
superior vena cava blocked: stent but face remains puffy
April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.
Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.
'Under no circumstances should you lose hope..' Dalai Lama